Search results
Marinus Pharmaceuticals Stock (NASDAQ:MRNS): This Drugmaker Boasts a Rare Treatment
TipRanks via Yahoo Finance· 3 months agoAmong the range of central nervous system (CNS) disorders afflicting patients in the U.S. each year,...
Marinus (MRNS) Up 20% on Financial and Pipeline Updates
Zacks via Yahoo Finance· 7 months agoMarinus' (MRNS) shares rise as it provides revenue and cash guidance for third-quarter 2023. The...
Marinus Pharmaceuticals Inc (MRNS) Reports Q3 2023 Financial Results
GuruFocus.com via Yahoo Finance· 6 months agoMarinus Pharmaceuticals Inc (NASDAQ:MRNS) reported a net loss of $32.972 million for Q3 2023,...
Wall Street Analysts Think Marinus Pharmaceuticals (MRNS) Could Surge 113.01%: Read This Before...
Zacks via Yahoo Finance· 3 months agoThe mean of analysts' price targets for Marinus Pharmaceuticals (MRNS) points to an 113% upside in...
Marinus Pharmaceuticals (MRNS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zacks via Yahoo Finance· 1 year agoMarinus Pharmaceuticals (MRNS) doesn't possess the right combination of the two key ingredients for...
Marinus Pharmaceuticals (MRNS) Soars 19.9%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 7 months agoMarinus Pharmaceuticals (MRNS) was a big mover last session on higher-than-average trading volume....
Marinus Pharmaceuticals, Inc.'s (NASDAQ:MRNS) top owners are individual investors with 34% stake,...
Simply Wall St. via Yahoo Finance· 1 year agoTo get a sense of who is truly in control of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), it is...
Marinus Pharmaceuticals (MRNS) Reports Q3 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 1 year agoMarinus Pharmaceuticals (MRNS) delivered earnings and revenue surprises of -240% and 91.81%,...
What Type Of Shareholders Make Up Marinus Pharmaceuticals, Inc.'s (NASDAQ:MRNS) Share Registry?
Simply Wall St. via Yahoo Finance· 2 years agoA look at the shareholders of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) can tell us which group is...
Marinus (MRNS) to Sell Rare Disease PRV to Novo Nordisk
Zacks via Yahoo Finance· 2 years agoMarinus Pharmaceutical MRNS entered into a definitive agreement to sell its Rare Pediatric Priority...